Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle

Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle
June 2004
Catherine D. Jepson and John B. March, Moredun Research Institute, Pentlands Science Park, Bush Loan, Penicuik EH26 0PZ, Scotland, UK
Vaccine Volume 22, Issue 19 , 23 June 2004, Pages 2413-2419
You can view the abstract online. A subscription is required to view the full text or it can be purchased online.
Abstract
The stability of whole bacteriophage small lambda, Greek particles, used as a DNA vaccine delivery system has been examined. Phage were found to be highly stable under normal storage conditions. In liquid suspension, no decrease in titre was observed over a 6-month period at 4 and -70 ?C, and phage stability was unaffected by freeze/thawing. The measured half life of phage in suspension was 36 days at 20 ?C, 3.4 days at 37 ?C and 2.3 days at 42 ?C. Freeze drying of a phage suspension (with or without the stabilizers dry skim milk or trehalose) resulted in 5?20% residual viability. Following desiccation (with or without stabilizers), measured half lives ranged from 20 to 100 days at 20 ?C, 2.6 to 38 days at 37 ?C, 2.1 to 26 days at 42 ?C, 7 to 33 h at 70 ?C, and 1.3 to 6 m at 100 ?C. In all cases the addition of trehalose significantly increased the stability of the desiccated phage. When stored at -70 ?C, desiccated phage appeared to be stable in the absence of stabilizers. When phage small lambda, Greek was diluted into water, a marginal loss in titre was observed over a 2-week period. Over a 24 h period, liquid phage suspensions were stable within the pH range pH 3?11, therefore oral administration of bacteriophage DNA vaccines via drinking water may be possible.